Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1219763

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1219763

Europe Body Fluid Collection And Diagnostics Market Size, Share & Industry Trends Analysis Report By Product, By Technology, By Sample Type, By Application, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 116 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Body Fluid Collection And Diagnostics Market would witness market growth of 6.5% CAGR during the forecast period (2022-2028).

Human body fluids are considered as the most adequate source for the clinical makers regarding the diagnosis of diseases. The benefit of body fluid testing is that they are less invasive, affordable, and can help in quick diagnostics.

Apart from this, altered protein expression profile in body fluid shows the conversion of the phycological states and cellular network of the disease or tissues. Therefore, the diagnostics through the body fluid has emerged as an outstanding approach to identify and discover the biomarkers or expose pathological mechanisms for human disease.

The examination of the human body fluid is fundamentally challenging because of its unique characteristics like protein complexity and the large active variety of protein collection, because of the extraordinary enhancement in the process of sample preparation, proteomics technology, and quantitation, with the increased sensitivity and robust experimental design it is now possible to examine body fluid more effectively.

In the United Kingdom people under age of 40 in the UK are being diagnosed with type 2 diabetes, at a faster rate. Also, the obese and overweight citizens in the nation are increasing rapidly. Due to this rising number of obese citizens, there are high chances of the people getting type 2 diabetes, especially among those aged 18 to 39. Almost 8% of the citizen with diabetes have type 1 diabetes and almost 90% of the citizen with diabetes have type 2 diabetes. This increasing number of diabetic patients will rise the growth opportunities for the body fluid collection and diagnostics market.

The Germany market dominated the Europe Body Fluid Collection And Diagnostics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,676.3 million by 2028. The UK market is anticipated to grow at a CAGR of 5.6% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 7.2% during (2022 - 2028).

Based on Product, the market is segmented into Kits & Consumables, Instruments and Tests/Services. Based on Technology, the market is segmented into Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Fluorescence in situ hybridization (FISH) and Others. Based on Sample Type, the market is segmented into Blood, Urine, Saliva and Cerebrospinal Fluid. Based on Application, the market is segmented into Diagnostics & Monitoring, Therapeutic Decision Making and Prognostics & Screening. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Qiagen N.V., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Biocept, Inc., MDxHealth SA, and Guardant Health, Inc.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Kits & Consumables
  • Instruments
  • Tests/Services

By Technology

  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Fluorescence in situ hybridization (FISH)
  • Others

By Sample Type

  • Blood
  • Urine
  • Saliva
  • Cerebrospinal Fluid

By Application

  • Diagnostics & Monitoring
  • Therapeutic Decision Making
  • Prognostics & Screening

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd.
  • Laboratory Corporation of America Holdings
  • Biocept, Inc.
  • MDxHealth SA
  • Guardant Health, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Body Fluid Collection And Diagnostics Market, by Product
    • 1.4.2 Europe Body Fluid Collection And Diagnostics Market, by Technology
    • 1.4.3 Europe Body Fluid Collection And Diagnostics Market, by Sample Type
    • 1.4.4 Europe Body Fluid Collection And Diagnostics Market, by Application
    • 1.4.5 Europe Body Fluid Collection And Diagnostics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2021, Jan - 2022, Sep) Leading Players

Chapter 4. Europe Body Fluid Collection And Diagnostics Market by Product

  • 4.1 Europe Kits & Consumables Market by Country
  • 4.2 Europe Instruments Market by Country
  • 4.3 Europe Tests/Services Market by Country

Chapter 5. Europe Body Fluid Collection And Diagnostics Market by Technology

  • 5.1 Europe Polymerase Chain Reaction (PCR) Market by Country
  • 5.2 Europe Next Generation Sequencing (NGS) Market by Country
  • 5.3 Europe Fluorescence in situ hybridization (FISH) Market by Country
  • 5.4 Europe Others Market by Country

Chapter 6. Europe Body Fluid Collection And Diagnostics Market by Sample Type

  • 6.1 Europe Blood Market by Country
  • 6.2 Europe Urine Market by Country
  • 6.3 Europe Saliva Market by Country
  • 6.4 Europe Cerebrospinal Fluid Market by Country

Chapter 7. Europe Body Fluid Collection And Diagnostics Market by Application

  • 7.1 Europe Diagnostics & Monitoring Market by Country
  • 7.2 Europe Therapeutic Decision Making Market by Country
  • 7.3 Europe Prognostics & Screening Market by Country

Chapter 8. Europe Body Fluid Collection And Diagnostics Market by Country

  • 8.1 Germany Body Fluid Collection And Diagnostics Market
    • 8.1.1 Germany Body Fluid Collection And Diagnostics Market by Product
    • 8.1.2 Germany Body Fluid Collection And Diagnostics Market by Technology
    • 8.1.3 Germany Body Fluid Collection And Diagnostics Market by Sample Type
    • 8.1.4 Germany Body Fluid Collection And Diagnostics Market by Application
  • 8.2 UK Body Fluid Collection And Diagnostics Market
    • 8.2.1 UK Body Fluid Collection And Diagnostics Market by Product
    • 8.2.2 UK Body Fluid Collection And Diagnostics Market by Technology
    • 8.2.3 UK Body Fluid Collection And Diagnostics Market by Sample Type
    • 8.2.4 UK Body Fluid Collection And Diagnostics Market by Application
  • 8.3 France Body Fluid Collection And Diagnostics Market
    • 8.3.1 France Body Fluid Collection And Diagnostics Market by Product
    • 8.3.2 France Body Fluid Collection And Diagnostics Market by Technology
    • 8.3.3 France Body Fluid Collection And Diagnostics Market by Sample Type
    • 8.3.4 France Body Fluid Collection And Diagnostics Market by Application
  • 8.4 Russia Body Fluid Collection And Diagnostics Market
    • 8.4.1 Russia Body Fluid Collection And Diagnostics Market by Product
    • 8.4.2 Russia Body Fluid Collection And Diagnostics Market by Technology
    • 8.4.3 Russia Body Fluid Collection And Diagnostics Market by Sample Type
    • 8.4.4 Russia Body Fluid Collection And Diagnostics Market by Application
  • 8.5 Spain Body Fluid Collection And Diagnostics Market
    • 8.5.1 Spain Body Fluid Collection And Diagnostics Market by Product
    • 8.5.2 Spain Body Fluid Collection And Diagnostics Market by Technology
    • 8.5.3 Spain Body Fluid Collection And Diagnostics Market by Sample Type
    • 8.5.4 Spain Body Fluid Collection And Diagnostics Market by Application
  • 8.6 Italy Body Fluid Collection And Diagnostics Market
    • 8.6.1 Italy Body Fluid Collection And Diagnostics Market by Product
    • 8.6.2 Italy Body Fluid Collection And Diagnostics Market by Technology
    • 8.6.3 Italy Body Fluid Collection And Diagnostics Market by Sample Type
    • 8.6.4 Italy Body Fluid Collection And Diagnostics Market by Application
  • 8.7 Rest of Europe Body Fluid Collection And Diagnostics Market
    • 8.7.1 Rest of Europe Body Fluid Collection And Diagnostics Market by Product
    • 8.7.2 Rest of Europe Body Fluid Collection And Diagnostics Market by Technology
    • 8.7.3 Rest of Europe Body Fluid Collection And Diagnostics Market by Sample Type
    • 8.7.4 Rest of Europe Body Fluid Collection And Diagnostics Market by Application

Chapter 9. Company Profiles

  • 9.1 Thermo Fisher Scientific, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Partnerships, Collaborations, and Agreements:
      • 9.1.5.2 Product Launches and Product Expansions:
      • 9.1.5.3 Acquisition and Mergers:
  • 9.2 Guardant Health, Inc.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Partnerships, Collaborations, and Agreements:
      • 9.2.5.2 Product Launches and Product Expansions:
      • 9.2.5.3 Acquisition and Mergers:
  • 9.3 Illumina, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Partnerships, Collaborations, and Agreements:
      • 9.3.5.2 Acquisition and Mergers:
  • 9.4 Qiagen N.V.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Partnerships, Collaborations, and Agreements:
      • 9.4.5.2 Acquisition and Mergers:
  • 9.5 Bio-Rad Laboratories, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expenses
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Partnerships, Collaborations, and Agreements:
      • 9.5.5.2 Product Launches and Product Expansions:
  • 9.6 F. Hoffmann-La Roche Ltd.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segmental and Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Product Launches and Product Expansions:
  • 9.7 Laboratory Corporation of America Holdings
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental Analysis
    • 9.7.4 Recent strategies and developments:
      • 9.7.4.1 Partnerships, Collaborations, and Agreements:
  • 9.8 Johnson & Johnson
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental &Regional Analysis
    • 9.8.4 Research & Development Expenses
  • 9.9 Biocept, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Research & Development Expenses
    • 9.9.4 Recent strategies and developments:
      • 9.9.4.1 Partnerships, Collaborations, and Agreements:
      • 9.9.4.2 Product Launches and Product Expansions:
  • 9.10. MDxHealth SA
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Regional Analysis
    • 9.10.4 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 Europe Body Fluid Collection And Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 2 Europe Body Fluid Collection And Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Body Fluid Collection And Diagnostics Market
  • TABLE 4 Product Launches And Product Expansions- Body Fluid Collection And Diagnostics Market
  • TABLE 5 Acquisition and Mergers- Body Fluid Collection And Diagnostics Market
  • TABLE 6 Europe Body Fluid Collection And Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 7 Europe Body Fluid Collection And Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 8 Europe Kits & Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 9 Europe Kits & Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 10 Europe Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 11 Europe Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 12 Europe Tests/Services Market by Country, 2018 - 2021, USD Million
  • TABLE 13 Europe Tests/Services Market by Country, 2022 - 2028, USD Million
  • TABLE 14 Europe Body Fluid Collection And Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 15 Europe Body Fluid Collection And Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 16 Europe Polymerase Chain Reaction (PCR) Market by Country, 2018 - 2021, USD Million
  • TABLE 17 Europe Polymerase Chain Reaction (PCR) Market by Country, 2022 - 2028, USD Million
  • TABLE 18 Europe Next Generation Sequencing (NGS) Market by Country, 2018 - 2021, USD Million
  • TABLE 19 Europe Next Generation Sequencing (NGS) Market by Country, 2022 - 2028, USD Million
  • TABLE 20 Europe Fluorescence in situ hybridization (FISH) Market by Country, 2018 - 2021, USD Million
  • TABLE 21 Europe Fluorescence in situ hybridization (FISH) Market by Country, 2022 - 2028, USD Million
  • TABLE 22 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 23 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 24 Europe Body Fluid Collection And Diagnostics Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 25 Europe Body Fluid Collection And Diagnostics Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 26 Europe Blood Market by Country, 2018 - 2021, USD Million
  • TABLE 27 Europe Blood Market by Country, 2022 - 2028, USD Million
  • TABLE 28 Europe Urine Market by Country, 2018 - 2021, USD Million
  • TABLE 29 Europe Urine Market by Country, 2022 - 2028, USD Million
  • TABLE 30 Europe Saliva Market by Country, 2018 - 2021, USD Million
  • TABLE 31 Europe Saliva Market by Country, 2022 - 2028, USD Million
  • TABLE 32 Europe Cerebrospinal Fluid Market by Country, 2018 - 2021, USD Million
  • TABLE 33 Europe Cerebrospinal Fluid Market by Country, 2022 - 2028, USD Million
  • TABLE 34 Europe Body Fluid Collection And Diagnostics Market by Application, 2018 - 2021, USD Million
  • TABLE 35 Europe Body Fluid Collection And Diagnostics Market by Application, 2022 - 2028, USD Million
  • TABLE 36 Europe Diagnostics & Monitoring Market by Country, 2018 - 2021, USD Million
  • TABLE 37 Europe Diagnostics & Monitoring Market by Country, 2022 - 2028, USD Million
  • TABLE 38 Europe Therapeutic Decision Making Market by Country, 2018 - 2021, USD Million
  • TABLE 39 Europe Therapeutic Decision Making Market by Country, 2022 - 2028, USD Million
  • TABLE 40 Europe Prognostics & Screening Market by Country, 2018 - 2021, USD Million
  • TABLE 41 Europe Prognostics & Screening Market by Country, 2022 - 2028, USD Million
  • TABLE 42 Europe Body Fluid Collection And Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 43 Europe Body Fluid Collection And Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 44 Germany Body Fluid Collection And Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 45 Germany Body Fluid Collection And Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 46 Germany Body Fluid Collection And Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 47 Germany Body Fluid Collection And Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 48 Germany Body Fluid Collection And Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 49 Germany Body Fluid Collection And Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 50 Germany Body Fluid Collection And Diagnostics Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 51 Germany Body Fluid Collection And Diagnostics Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 52 Germany Body Fluid Collection And Diagnostics Market by Application, 2018 - 2021, USD Million
  • TABLE 53 Germany Body Fluid Collection And Diagnostics Market by Application, 2022 - 2028, USD Million
  • TABLE 54 UK Body Fluid Collection And Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 55 UK Body Fluid Collection And Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 56 UK Body Fluid Collection And Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 57 UK Body Fluid Collection And Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 58 UK Body Fluid Collection And Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 59 UK Body Fluid Collection And Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 60 UK Body Fluid Collection And Diagnostics Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 61 UK Body Fluid Collection And Diagnostics Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 62 UK Body Fluid Collection And Diagnostics Market by Application, 2018 - 2021, USD Million
  • TABLE 63 UK Body Fluid Collection And Diagnostics Market by Application, 2022 - 2028, USD Million
  • TABLE 64 France Body Fluid Collection And Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 65 France Body Fluid Collection And Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 66 France Body Fluid Collection And Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 67 France Body Fluid Collection And Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 68 France Body Fluid Collection And Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 69 France Body Fluid Collection And Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 70 France Body Fluid Collection And Diagnostics Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 71 France Body Fluid Collection And Diagnostics Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 72 France Body Fluid Collection And Diagnostics Market by Application, 2018 - 2021, USD Million
  • TABLE 73 France Body Fluid Collection And Diagnostics Market by Application, 2022 - 2028, USD Million
  • TABLE 74 Russia Body Fluid Collection And Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 75 Russia Body Fluid Collection And Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 76 Russia Body Fluid Collection And Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 77 Russia Body Fluid Collection And Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 78 Russia Body Fluid Collection And Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 79 Russia Body Fluid Collection And Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 80 Russia Body Fluid Collection And Diagnostics Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 81 Russia Body Fluid Collection And Diagnostics Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 82 Russia Body Fluid Collection And Diagnostics Market by Application, 2018 - 2021, USD Million
  • TABLE 83 Russia Body Fluid Collection And Diagnostics Market by Application, 2022 - 2028, USD Million
  • TABLE 84 Spain Body Fluid Collection And Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 85 Spain Body Fluid Collection And Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 86 Spain Body Fluid Collection And Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 87 Spain Body Fluid Collection And Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 88 Spain Body Fluid Collection And Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 89 Spain Body Fluid Collection And Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 90 Spain Body Fluid Collection And Diagnostics Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 91 Spain Body Fluid Collection And Diagnostics Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 92 Spain Body Fluid Collection And Diagnostics Market by Application, 2018 - 2021, USD Million
  • TABLE 93 Spain Body Fluid Collection And Diagnostics Market by Application, 2022 - 2028, USD Million
  • TABLE 94 Italy Body Fluid Collection And Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 95 Italy Body Fluid Collection And Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 96 Italy Body Fluid Collection And Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 97 Italy Body Fluid Collection And Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 98 Italy Body Fluid Collection And Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 99 Italy Body Fluid Collection And Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 100 Italy Body Fluid Collection And Diagnostics Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 101 Italy Body Fluid Collection And Diagnostics Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 102 Italy Body Fluid Collection And Diagnostics Market by Application, 2018 - 2021, USD Million
  • TABLE 103 Italy Body Fluid Collection And Diagnostics Market by Application, 2022 - 2028, USD Million
  • TABLE 104 Rest of Europe Body Fluid Collection And Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 105 Rest of Europe Body Fluid Collection And Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 106 Rest of Europe Body Fluid Collection And Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 107 Rest of Europe Body Fluid Collection And Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 108 Rest of Europe Body Fluid Collection And Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 109 Rest of Europe Body Fluid Collection And Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 110 Rest of Europe Body Fluid Collection And Diagnostics Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 111 Rest of Europe Body Fluid Collection And Diagnostics Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 112 Rest of Europe Body Fluid Collection And Diagnostics Market by Application, 2018 - 2021, USD Million
  • TABLE 113 Rest of Europe Body Fluid Collection And Diagnostics Market by Application, 2022 - 2028, USD Million
  • TABLE 114 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 115 Key Information - GUARDANT HEALTH, INC.
  • TABLE 116 key information - Illumina, Inc.
  • TABLE 117 Key Information - Qiagen N.V.
  • TABLE 118 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 119 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 120 Key Information - Laboratory Corporation of America holdings
  • TABLE 121 Key information -Johnson & Johnson
  • TABLE 122 Key Information -Biocept, Inc.
  • TABLE 123 Key Information - MDXHEALTH SA

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements : 2021, Jan - 2022, Sep) Leading Players
  • FIG 5 Recent strategies and developments: Thermo Fisher Scientific, Inc.
  • FIG 6 Recent strategies and developments: Guardant Health, Inc.
  • FIG 7 Recent strategies and developments: Illumina, Inc.
  • FIG 8 Recent strategies and developments: Qiagen N.V.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!